Are you Dr. Olson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Summary
- Dr. Amanda Olson, MD is a board certified family physician in Nashville, Tennessee. She is currently licensed to practice medicine in Tennessee, Alabama, and South Carolina. She is affiliated with Vanderbilt University Medical Center.
Education & Training
- Prisma Health/University of South Carolina SOM Columbia (Columbia)Residency, Family Medicine, 2011 - 2014
- Wright State University Boonshoft School of MedicineClass of 2011
Certifications & Licensure
- TN State Medical License 2014 - 2025
- AL State Medical License 2020 - 2020
- SC State Medical License 2011 - 2014
- American Board of Family Medicine Family Medicine
Publications & Presentations
PubMed
- 48 citationsSynthesis and evaluation of a new generation of orally efficacious benzimidazole-based poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors as anticancer agents.Yunsong Tong, Jennifer J. Bouska, Paul A. Ellis, Eric F. Johnson, Joel D. Leverson
Journal of Medicinal Chemistry. 2009-10-21 - 179 citationsDiscovery of the Poly(ADP-ribose) Polymerase (PARP) Inhibitor 2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide (ABT-888) for the Treatment of CancerThomas D. Penning, Gui-Dong Zhu, Viraj B. Gandhi, Jianchun Gong, Xuesong Liu
Journal of Medicinal Chemistry. 2009-01-22 - 581 citationsABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor ModelsCherrie K. Donawho, Yan Luo, Yanping Luo, Thomas D. Penning, Joy Bauch
Clinical Cancer Research. 2007-05-01